We have previously demonstrated that CHK2 is a critical negative regulator of AR 20 transcriptional activity, PCa cell growth, and androgen sensitivity. We have now 21 uncovered that the AR directly interacts with CHK2, and ionizing radiation (IR) increases 22
this interaction, which crests one hour after IR-induced DNA damage. This IR-induced 23 increase in CHK2-AR interactions requires AR phosphorylation on both serine81 and 24 serine308 and CHK2 kinase activity. Kinase-impaired CHK2 variants, including the 25 K373E variant associated with 4.2% of PCa, blocked IR-induced CHK2-AR interactions. 26
The destabilization of CHK2-AR interactions induced by the CHK2 variants impairs CHK2 27 function as a negative regulator of cell growth. CHK2 depletion in LNCaP cells increases 28 transcription of DNAPK and RAD54 and increases clonogenic survival. The data support 29 a model where CHK2 sequesters the AR through direct binding which in turn decreases 30 AR transcription and leads to suppression of PCa cell growth.
INTRODUCTION 32
Mammalian cells are continuously being bombarded by endogenous and 33 exogenous forces that jeopardize the integrity of DNA. In response to DNA damage, a 34 conserved network of signaling pathways known as the DNA damage response (DDR) is 35 activated to maintain cell viability and genome stability [1] . Prostate cancer (PCa) remains 36 one of the leading causes of death among men of all races (cdc.gov), as castration-37 resistant prostate cancer (CRPC) is currently incurable. Recently, the DDR has been a 38 focus of PCa research since the androgen receptor (AR), a major driver of PCa, 39 modulates the transcription of DDR genes [2] and DNA repair [3] . We have previously 40
shown that checkpoint kinase 2 (CHK2) negatively regulates androgen sensitivity and 41 PCa cell growth [4] . 42 CHK2 is a serine/threonine protein kinase that plays a crucial role in sensing DNA 43 damage and initiating the DDR, comprising of cell cycle arrest, DNA repair, and apoptosis 44 [5] . CHK2 consists of an amino-terminal SQ/TQ cluster domain (SCD) where threonine 45 68 serves as a substrate for phosphorylation by ataxia-telangectasia mutated (ATM) 46 kinase [6]; a carboxy-terminal kinase domain (KD) and nuclear localization sequence [7] ; 47 and a central forkhead-associated domain (FHA) that provides an interface for 48 interactions with phosphorylated proteins [8] . Currently, there are approximately 24 CHK2 49 substrates in human cells that have been experimentally validated, including polo-like 50 kinase 1 (PLK1), promyelocytic leukemia protein (PML), E2F1, p53, and cell division cycle 51 25C (CDC25C) [9] . These studies show that one mechanism CHK2 utilizes to affect 52 cellular function is through direct protein-protein interactions. 53
RESULTS

87
CHK2 directly binds AR 88
We previously showed that AR coimmunoprecipitated with CHK2 immune 89 complexes in several prostate cancer cell lines [4] . To determine whether this co-90 association was through direct protein-protein interaction, we performed far western 91 blotting. To generate purified protein for the far westerns, 293T cells were transfected 92 with mammalian plasmids expressing Flag-wtAR, Flag-ERK2, or V5-wtCHK2 ( Fig. 1A) . 93
We used Flag-ERK2 as a positive control since it has been reported that CHK2 physically 94 associated with ERK1/2 in cancer cells [16] . Flag-ERK and Flag-wtAR targets were 95 immunoaffinity purified and resolved by SDS-PAGE. The target proteins (AR and ERK) 96 on the membrane were probed with purified V5-wtCHK2 protein, crosslinked, and stained 97 with V5 antibodies to detect bound V5-wtCHK2. Membranes were also immunoblotted 98 with AR and ERK1/2 antibodies to confirm that the molecular weight of AR and ERK1/2 99 corresponded with the CHK2 signal, which then indicates direct protein-protein 100 interaction. We found that V5-wtCHK2 bound to Flag-wtAR, as well as the control Flag-101 ERK2. Moreover, we observed similar results when we performed the converse 102 experiment and observed that the HA-wtAR probe directly associated with the target 103 protein Flag-wtCHK2 ( Fig. 1B) . These data indicate that the interaction of AR with CHK2 104 is authentic and direct. 105
Radiation increases CHK2-AR association 106
Since IR is a standard of care for patients with localized advanced prostate cancer 107 and CHK2 is a known mediator of the DDR, we wanted to assess the impact of IR on 108 CHK2-AR interactions. To examine the effect of radiation on the binding of AR to CHK2, 109 hormone-sensitive LNCaP and castration-resistant Rv1 cells were exposed to 6Gy IR, 110 which is representative of the fractionated dose of IR prostate cancer patients receive 111 [17] . CHK2 immune complexes were generated one hour following radiation. The AR 112 signal was quantified and normalized to total CHK2 protein ( Fig. 2 ). IR significantly 113 increased endogenous CHK2-AR immune complexes by 2-fold and 1.8-fold in LNCaP 114 ( Fig. 2A) and Rv1 ( Fig. 2B ) cells, respectively. Rv1 cells also express AR variant 7 (AR V7 ), 115 which is a truncated isoform of AR that lacks the ligand binding domain (LBD) [18] . 116
Interestingly, endogenous AR V7 also bound endogenous CHK2, and IR induced a similar 117 increase in CHK2 -AR V7 complexes as that observed with full length AR. Thus, these 118 results suggest that IR drives CHK2 to bind both full length and variant AR. 119
To further characterize the effect of radiation on CHK2-AR associations, we 120 evaluated the kinetics of the increase in CHK2-AR protein complexes in response to IR. 121 CHK2 was immunoprecipitated from irradiated LNCaP and C4-2 cells 1, 4, and 24 hours 122 following IR exposure ( Fig. 2C ). We found that AR was maximally bound to CHK2 one 123 hour after radiation treatment in both cell lines. This interaction was dramatically reduced 124 to near baseline levels by 4hrs, and returned to baseline levels 24hrs after IR. 125
Interestingly, we noticed that the temporal protein binding of CHK2 to AR paralleled the 126 activation state of CHK2, as represented by CHK2 phosphorylation on threonine 68 ( Fig.  127 2C) [Matsuoka, 1998 ]. Thus, these data show that the CHK2-AR protein complexes are 128 transient, cresting one hour following IR. Furthermore, these observations suggest that 129 the interaction between CHK2 and AR may be regulated by the activation state of CHK2. 130
AR phosphorylation regulates CHK2-AR interaction 131
The phosphorylation of AR on serine 81 (S81) by CDK1 and CDK9 stimulates AR 132 transcriptional activity and growth of PCa cells [19]- [21] . Whereas, AR phosphorylation 133 on serine 308 (S308) represses transcription and proliferation and alters AR localization 134 during mitosis [22] , [23] . To address whether S81 or S308 phosphorylation influences 135 CHK2-AR complexes, LNCaP cells were transduced with lentiviral particles containing 136 wtAR or AR mutants S81A or S308A (Fig. 3A) . The association of AR was analyzed from 137 endogenous CHK2 immune complexes generated one hour after irradiation. There was 138 a 4-fold increase in AR co-immunoprecipitating with CHK2 after IR treatment of cells 139 expressing wtAR. However, neither S81A nor S308A increased in association with CHK2 140 upon IR treatment indicating that phosphorylation of AR on S81 and S308 are required 141 for the IR-induced increase in the interaction between CHK2 and AR. 142
The requirement for irradiation of AR expressing target cells and AR 143 phosphorylation for the IR-induced increase in CHK2-AR association led us to test if AR 144 phosphorylation on S81 and S308 were increased in response to IR. AR was 145 immunoprecipitated from irradiated cells, and phospho-S81 and phospho-S308 were 146 measured by western blotting using phospho-specific antibodies to those sites [20], [24] 147 (Supplemental Figure 1 ). There were no significant consistent changes in S81 or S308 148 phosphorylation in response to radiation in either cell line. Thus, these findings indicate 149 that while the intensity of S81 and S308 phosphorylation does not markedly change with 150 IR, S81 and S308 phosphorylation is required for CHK2-AR interactions. 151
CHK2 kinase activity is required for CHK2-AR interaction 152
To determine if CHK2 kinase activity was necessary for the CHK2-AR association, 153
we tested if CHK2 mutants that are found in PCa and have impaired kinase activity could 154 interact with the AR, and if that interaction increased with IR. We expressed Flag-155 wtCHK2, Flag-K373E, or Flag-T387N in combination with HA-wtAR in LNCaP cells. The 156 K373E CHK2 mutation impairs CHK2 function suppressing cell growth and promoting 157 survival in response to IR, as a result of reduced kinase activity due to the disruption of 158 CHK2 autophosphorylation [25] . Less is known about the heterozygous missense 159 mutation T387N, but it is reported to diminish kinase activity, and thus, CHK2 function 160
[26]. Flag-CHK2 immunoprecipitations were performed and HA-AR association was 161 evaluated ( Fig. 3B ). In response to IR there was a striking increase in CHK2-AR co-162 association in cells expressing Flag-wtCHK2 and HA-wtAR. However, the amount of IR-163 induced increase in CHK2-AR association in cells expressing either K373E or T387N 164 was dramatically reduced. Therefore, these data indicate that the kinase activity of CHK2 165 is required for the interactions of CHK2 and AR, and that the CHK2 mutant associated 166 with PCa, T387N, has a diminished ability to interact with the AR. 167
IR increases direct CHK2-AR binding 168
To both confirm that IR induces the increase of CHK2-AR protein complexes and 169 determine if the increase is due to direct protein-protein interaction, we carried out far 170 western blotting where target (Flag-wtAR and Flag-ERK2) or probe proteins (V5-wtCHK2) 171
were isolated from cells either irradiated with 6Gy 48hrs following transient transfection, 172 and purified one hour after radiation exposure, or kept untreated prior to immunoaffinity 173 purification of target and probe proteins. When the cells expressing the V5-wtCHK2 probe 174
and Flag-wtAR target were irradiated there was a 2-fold increase in V5-wtCHK2 binding 175 to the target Flag-wtAR in response to IR ( Fig. 4A ). However, when the V5-wtCHK2 probe 176 was not treated with IR, no increase in probe binding to target was observed ( Fig. 4B ).
Together, these data indicate that radiation of cells expressing the V5-wtCHK2 probe is 178 required for the increased CHK2-AR interaction that occurs in response to IR. Since IR 179 increases the activity state of CHK2 as measured by phosphorylation of CHK2, this result 180 supports the above data indicating that CHK2 kinase activity is required for the IR induced 181 CHK2-AR association. 182
AR and CHK2 activity required for direct CHK2-AR binding 183
To determine whether AR activity is required for the increase in CHK2-AR direct 184 binding in response to IR, far westerns were again performed by treating 293T cells 185 expressing Flag-wtAR, Flag-ERK2, or V5-wtCHK2 with 6Gy ionizing radiation in the 186 presence or absence of the anti-androgen Enzalutamide (Fig. 5A ). As expected, far 187 western blots revealed that radiation increased purified CHK2 binding to purified AR by 188 2-fold. The presence of enzalutamide blocked the IR induced increase in CHK2-AR 189
interaction, suggesting that transcriptionally activated AR is required for the IR-induced 190 increase in association of CHK2 and AR. This is consistent with the loss of AR 191 phosphorylation on S81 decreasing the CHK2-AR association. 192 CHK2 activity is also required for the direct CHK2-AR binding in response to IR. 193 In parallel to the far western in Fig 5A, we performed far westerns with the cells expressing 194 the V5-CHK2 probe pre-treated with the CHK2 inhibitor BML-277 one hour prior to IR. 195 ( Fig. 5B ). Remarkably, inhibition of CHK2 kinase activity completely blocked the increase 196 in CHK2-AR interactions that we observed when the probe was irradiated in the absence 197 of BML-277 ( Fig. 5A ). We also did not detect increased binding to the control target Flag-198 AR transcription of DNA repair genes suggested the hypothesis that loss of CHK2 could 246 facilitate DNA repair. 247
To assess the effect of IR-induced DNA damage in the presence or absence of 248 CHK2 knockdown we performed comet assays, which measures DNA breaks [28], and 249 immunofluorescence staining of phospho-gH2AX, a marker for DNA double-strand breaks 250
[29], [30] . Since the majority of IR induced DSBs are repaired rapidly [29], [31] we focused 251 on early timepoints following DNA damage. Neither LNCaP or Rv1 cells showed a change 252 in IR induced comet tail moment following 1 hour of IR (Supplemental Figure 2 ). In order 253 to quantify phospho-gH2AX foci in an unbiased manner we developed an approach that 254 utilizes automated quantitation of immunofluorescence that enables us to rapidly 255 determine the signal intensity (Supplemental Figure 3 ). LNCaP cells were transduced 256 with vector or CHK2 shRNA 48hrs before delivery of IR. Radiation induced similar levels 257 of DNA damage 15min after exposure regardless of CHK2 expression ( Fig.8B,C) . 258
However, CHK2 knockdown exhibited a significant increase in phospho-gH2AX signal 259 compared to vector control cells 45min after IR. gH2AX is phosphorylated in response to 260 inputs in addition to IR induced DNA double strand breaks including RNA polymerase II 261 dependent transcription [32]-[34]. Thus, the apparent discrepancy in the comet and 262 gH2AX foci assay may be explained by the increase in AR transcription when CHK2 is 263 knocked down as in Figure 7 and in our previous study [4] . 264
Since superphysiological doses of androgen has been associated with other hand, showed that increased clonogenic survival following IR was a consequence 297 of DNA-PKc directly complexing with both FL-AR and AR V5-7 , with radiation increasing 298 these interactions and enzalutamide blocking the association with FL-AR but not AR V5-7 299 [45] . These data support a model where AR is integrated in the DDR, interfacing at 300 multiple points in the DDR. 301
We show that the association of CHK2 and AR requires phosphorylation of AR on 302 S81 and S308. Since proteins containing FHA domains bind phosphoproteins [8], we 303 hypothesize that AR interacts with CHK2 through the CHK2 FHA domain. In support of 304 this, the Zhao lab determined that AR physically associated with the FHA domain of 305 another critical DDR member, MDC1 [44] . Expression of truncation mutants of different 306 MDC1 domains in LNCaP cells led to the discovery that AR only co-immunoprecipitated 307 with MDC1 mutants containing the FHA domain in the absence and presence of 308 dihydrotestosterone. Their results indicated that the FHA domain of MDC1 mediated the 309 interaction with AR. Here we report that AR phosphorylation on S81 and S308 is required 310 for CHK2-AR binding. Interestingly neither of these phosphorylation sites were altered by 311 IR. AR S81 and S308 can both be phosphorylated by CDK1, which is downstream of 312 canonical CHK2 signaling [21], [24] , and was the motivation for us examining these sites 313 in response to IR. The prediction is that IR would lead to a decrease in S81 and S308 314 phosphorylation. However, our previous studies demonstrated that S81 is predominantly 315 phosphorylated by CDK9, and thus is more indicative of AR transcriptional activity [20] . 316
We also found that S308 phosphorylation was restricted to late G2 and M phase of the 317 cell cycle [24] . CDK9 phosphorylation of S81 and the restriction of S308 phosphorylation 318 to G2/M likely accounts for not observing significant changes in these phosphorylation 319 sites in response to IR. The disconnect between these sites being required for the IR induced increase in CHK2-AR association but not being regulated by IR suggests that 321 the hormone induced activation state of the AR is a critical determinant in the IR induced 322 increase in CHK2-AR association. 323
In our experiments examining CHK2-AR binding, we used ERK as a positive 324 control for a protein that interacts with CHK2 [16]. Interestingly, we observed a significant 325 increase in CHK2-ERK association with IR. This is consistent with IR increasing CHK2 326 T68 phosphorylation, which is required for the CHK2-ERK interaction. These data point 327 to a potential larger role for CHK2 beyond canonical DDR and cell cycle checkpoint 328 signaling; consistent with this notion CHK2 has been implicated in diverse cellular 329 processes [46] - [48] . MEK inhibition is effective in lung tumors with ATM mutations where 330 CHK2 is inactive [49] providing further support that CHK2 negatively regulates ERK. 331 CHK2 negatively regulating both the AR and ERK suggests the hypothesis that CHK2 332 may serve as a general negative regulator of mitogenic signals in response to IR. 333
We found that CHK2 variants with diminished kinase activity impaired the IR-334 induced increase in CHK2-AR interaction but did not completely block the CHK2-AR 335 interaction. This correlated with a reduced inhibition of cell growth by the CHK2 variants. 336 CHK2-depleted cells re-expressing CHK2 variants exhibited an approximate 2-3-fold 337 reduction in growth inhibition in response to hormone when compared to cells re-338 expressing wtCHK2. Moreover, the fold change in suppression of growth between 339 wtCHK2 and CHK2 variants was greater in androgen-dependent LNCaP cells than in 340 castration-resistant C4-2 and Rv1 cells, suggesting that in hormone sensitive PCa CHK2 341 variants may play a larger role in regulating growth. Berge and colleagues discovered 342 numerous CHK2 splice variants in breast cancer tissue, where all variants were co-expressed with wtCHK2 [50]. Furthermore, several of these variants reduced kinase 344 activity when simultaneously expressed with wtCHK2 and displayed a dominant negative 345 effect on wtCHK2. The impact of the CHK2 variants found in PCa on wtCHK2 function 346
has not yet been fully explored. 347
Multiple studies indicate that the AR is a critical regulator of genes in the DDR [2], 348 [3] . Reports by others demonstrate that androgen and IR increased DNAPK, XRCC2, and 349 XRCC3 [3] . This concept was supported by more global analysis of transcripts 350 demonstrating androgen regulation of DDR genes [2] . Our data indicating that CHK2 351 knockdown increases DNAPK and RAD54 transcript levels leads to the hypothesis that 352 CHK2 binding to the AR suppresses AR transcription of DDR genes enabling cells to turn 353 off the DDR following DNA repair. This is consistent with our earlier observation that 354 CHK2 knockdown led to the increase in the transcripts of canonical AR target genes [4] . 355
We observed radiation resistance in CHK2 knockdown cells, consistent with CHK2 356 suppression of AR transcription of DDR genes. We also observed an increase in 357 phospho-gH2AX signal when CHK2 was knocked down, but no change in DNA breaks as 358 measured by the comet assay under similar conditions. These paradoxical results may 359 be explained by phosphorylation of gH2AX in response to transcription induced DNA 360 breaks [32]-[34]. These incongruous results may also be due to competing effects of 361 CHK2 as both a regulator of the cell cycle and apoptosis [46] . 362
The data reported herein along with our previous work [4] indicate that CHK2 acts 363 as a tumor suppressor in PCa, either through loss of expression or mutation. This raises 364 the concern that CHK2 antagonists in clinical development may paradoxically lead to 365 enhanced PCa growth and resistance to IR. However, it is important to note that we have predominately used a RNAi/overexpression approach. Our RNAi approach is more similar 367 to the CHK2 variants in PCa that have reduced kinase activity. It is important to consider 368 that pharmacologic inhibition is different than inhibition by RNAi [51] . A pharmacologic 369 approach that provides a sudden and complete inhibition of CHK2 kinase activity may 370 impact PCa differently than our RNAi approach, especially when combined with IR or AR 371 antagonists. Our work and that in the literature also suggests that approaches 372 downstream of CHK2 may be more straightforward than targeting CHK2. 373
In this study, we presented data that provides mechanistic insight into our 374 observation that CHK2 negatively regulates PCa growth. We demonstrated that AR 375 directly bound CHK2, and that IR elevated the CHK2-AR interaction, which peaked one 376 hour following exposure. Not only did these CHK2-AR protein complexes require AR 377 phosphorylation on both serine 81 and serine 308, but CHK2 kinase activity was also 378 necessary, as CHK2 kinase inhibitors disrupted CHK2-AR binding. This was verified 379 using kinase-impaired CHK2 variants, including the K373E variant associated with 4.2% 380 of prostate cancer. Furthermore, these CHK2 variants exhibited a diminished effect on 381 restricting prostate cancer cell growth. We observed that knockdown of CHK2 led to an 382 increase in PCa cell survival in response to IR. This suggests that the deregulation of 383 CHK2 in PCa compromises the DDR and can confer resistance to radiation. In a previous 384 study, we showed that CHK2 knockdown hypersensitized PCa cells to castrate levels of 385 androgen and increased AR transcriptional activity on both androgen-activated and 386 androgen-repressed genes [4] . As part of a feedback loop, AR transcriptionally represses 387 CHK2 levels. Thus, these data along with our previously published results suggest a 388 model where CHK2 antagonizes AR through direct binding and inhibition of transcription 389 of AR targets, including DDR genes (Figure 9 ). The K373E mutation of CHK2 or loss of 390 CHK2 expression in PCa leads to increased AR transcriptional activity and survival in 391 response to DNA damage, all leading to a more aggressive cancer. Collectively, the work 392 provides a foundation for the continued study of CHK2-AR interactions and functional 393 consequences to benefit PCa therapies. ImmunoResearch). Western blotting performed as previously described [4] . 413
Far Western Blot 414
To measure direct protein interactions, the protocol was adapted from Prickett et times with PBS for 5min followed by fixation using 0.5% paraformaldehyde for 30 min at 427 room temperature. Membranes were then rinsed quickly twice with PBS and quenched 428 using 2% glycine in PBS for 10 min at room temperature. The membrane was blotted for 429 Flag, HA, V5, AR, CHK2, or ERK1/2 and analyzed using the LI-COR Odyssey system 430 and software. 431
Immunoprecipitation 432 CHK2 or AR protein was immunoprecipitated from 1mg cell lysate from LNCaP, 433 C42, and Rv1 cells cultured in the appropriate growth media or LNCaP cells transiently 434 transfected with Flag-wtAR/Flag-S81A/Flag-S308A plus V5-wtCHK2 or Flag-435 wtCHK2/Flag-K373E/Flag-T387N plus HA-wtAR for 48hrs; treated with radiation. 436
Immunoprecipitations were performed with either agarose or magnetic beads, proteins 437 were separated by 7.5% SDS-PAGE; and immunoblotted with AR, pAR S81, pAR S308, 438 CHK2, pCHK2 T68, HA, or ERK1/2 antibodies. 439
CyQuant Growth Assays 440
Assay was performed as previously described [4] 
Clonogenic Survival Assay 457
LNCaP cells were transduced with lentiviral particles expressing vector or CHK2 458 shRNAs and treated with 0-6Gy of radiation 72hrs after transduction. Cells were 459 trypsinized, counted, and appropriate numbers were plated in triplicate with the 460 appropriate growth media for colony formation assays (100 cells/0Gy, 200 cells/2Gy, 461 1000 cells/4Gy, and 6000 cells/6Gy). After 10-14 days, colonies consisting of 50-70 cells 462 were counted using crystal violet. Plotted is the surviving fraction (number of colonies counted/number of cells seeded) following radiation. 465
Comet Assay 466
All Comet Assay steps were performed in the dark. Cells were washed twice with 467 PBS , scraped and suspended in PBS. Cells were combined with molten LMAgarose 468 (Trevigen, 4250-050-02) and placed into comet suitable sides. Samples were left at 4°C 469 for 15 minutes order to create flat surface. Slides were immerse in lysis solution (Trevigen, 470 4250-050-01) for 40 minutes at 4°C and then in alkaline solution for 30min at room 471 temperature. Slides were electrophoresed in 200mM NaOH, 1mM EDTA in water; pH>13 472 at 21Volts (300mA) for 30 minutes at 4°C. After the electrophoresis, slides were gently 473 drained, washed twice in dH2O for 10min and immersed in 70% ethanol for 5min. 474
Samples were left to dry overnight at RT. Samples were stained with SYBR Green at 4°C 475 for 5 minutes and left to dry completely overnight. For quantification, images were 476 acquired using a fluorescence microscope (Olympus BX51, High-mag) equipped with a 477 20×, 0.5 NA objective and a camera (DP70). Images were acquired with DPController 478 software. Images were analyzed by ImageJ software and graphs generated using Prism 479 (GraphPad Software). All imaging was performed at ∼24°C. 480
Immunofluorescence (IF) 481
LNCaP cells were transduced with lentivirus expressing vector or CHK2 shRNAs 482 on 1µg/ml fibronectin-coated coverslips and treated with radiation 48hrs after 483 transduction. Cells were allowed to recover from IR exposure for 0, 15, and 45mins. 484
Coverslips were washed 3X with PBS, permeabilized with 0.2% Triton-X for 10mins, 485 blocked with 2% FBS/BSA/donkey serum in PBS for 2hrs at room temperature, and 486 incubated with gH2AX antibodies overnight at 4°C. Coverslips were mounted with 487 Vectashield containing DAPI (ThermoFisher), and images were acquired with a LSM 880 488 confocal microscope (Carl Zeiss). gH2AX signals were measured using ImageJ software. radiation. LNCaP and C4-2 cells were seeded in serum-supplemented growth media for 764 48hrs, exposed to 6Gy IR, and AR was immunoprecipitated using a magnetic bead 765 system 1hr after radiation from 1mg cell extracts. Proteins were separated by 7.5% SDS-766 PAGE, and blotted with AR, pAR S81, pAR S308, CHK2, and ERK1/2. Representative 767 blots are shown. Plotted is the pAR signal normalized to total AR and compared to 768 untreated cells, n=3, no statistical difference between the groups by ANOVA. Blots were 769 quantitated on Odyssey LICOR imaging system. 770 Figure 4 
